Evidence map›Paper›PMID 23292125›Full record

ArticleHuman vaccines & immunotherapeutics2013

Epitope-specific immune recognition of the nontypeable Haemophilus influenzae outer membrane protein 26.

Duangkamol Kunthalert, Laura A Novotny, Helen M Massa, Glen C Ulett, Lauren O Bakaletz, Jennelle M Kyd, Allan W Cripps

Open access · bronzeAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Panel 6: Vaccines.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Duangkamol KunthalertFaculty of Medical Science; Naresuan University; Phitsanulok, Thailand.
Laura A Novotny
Helen M Massa
Glen C Ulett
Lauren O Bakaletz
Jennelle M Kyd
Allan W Cripps
Griffith University · AUColumbus Oncology and Hematology Associates · USDefence Materials Technology Centre (Australia) · AUNaresuan University Hospital · THNationwide Children's Hospital · USTAFE Queensland Gold Coast · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies using rodent respiratory infection models of nontypeable Haemophilus influenzae (NTHi) infection have established the 26-kDa outer membrane protein of the bacterium, OMP26, as a potential vaccine antigen for NTHi. This study undertook a comprehensive immunological identification of OMP26 T- and B-cell epitopes. A series of OMP26 peptides were constructed and regions of the OMP26 antigen involved in recognition by lymphocyte receptors and induction of acquired immune responses were identified. The dominant T-cell epitopes for OMP26 were located toward the C-terminus between amino acid residues 95 and 197 (T3+T4 region) as mapped using antigen-specific lymphocyte proliferation assays. The newly identified T-cell epitopes exhibited strong capacity for efficient T-cell activation, suggesting that, compared with other OMP26 regions; epitopes within the T3+T4 region have the highest affinity for binding to major histocompatibility complex molecules. In contrast, the predominant B-cell epitopes of OMP26 were located more centrally within the molecule between amino acid residues 45 and 145 (T2+T3 region) as determined using enzyme-linked immunosorbent assay and surface plasmon resonance assays. The T2+T3 region was immunodominant in several species including chinchilla, mice and rats when assessed using both mucosal and parenteral immunization regimes. In addition, the antibodies directed against the T2+T3 region bound to intact NTHi cell surface, according to flow cytometry. Collectively, these results specifically locate the amino acid sequences containing the OMP26 T- and B-cell epitopes, which, as newly mapped antigenic epitopes for lymphocyte recognition, will be useful to improve existing NTHi vaccine strategies. Comprehensive definition of the minimum epitope length required for optimal B- and T-cell responses requires further study.

Indexed as

Epitope MappingAnimalsBacterial Outer Membrane ProteinsCell ProliferationChinchillaEnzyme-Linked Immunosorbent AssayEpitopes, B-LymphocyteEpitopes, T-LymphocyteHaemophilus influenzaeImmunodominant EpitopesMaleMice, Inbred BALB CRatsSurface Plasmon ResonanceT-LymphocytesBacterial Outer Membrane ProteinsEpitopes, B-LymphocyteEpitopes, T-LymphocyteImmunodominant EpitopesOMP26 protein, Haemophilus influenzaeB and T-cell epitopesimmune responsemucosalnontypeable Haemophilus influenzaeOMP26outer membrane proteinparenteralpeptide vaccinevaccine

Identifiers

PMID23292125
PMCPMC3891721
OpenAlexW1964675633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.